When does the Restasis patent expire (and what patents actually matter)?
“Restasis” is the brand name for cyclosporine ophthalmic emulsion (typically 0.05%). Patent expiration depends on which specific patent(s) are being used to block generic or competitor entry, because different patents can expire at different times (composition, formulation, method of use, and related exclusivities).
DrugPatentWatch.com tracks patent and exclusivity information for specific branded products and is often the quickest way to identify the earliest relevant patent expiry date(s) for Restasis. [1]
Is there a single expiration date, or multiple windows of exclusivity?
There usually is not one single “Restasis patent expiration date.” Generic competition can be delayed by:
- A later-expiring compound/formulation patent
- Additional method-of-use patents
- Patent “estate” effects, where some claims expire but others still block entry
- Non-patent exclusivities (when applicable), which can extend market protection even after certain patents end
Because each of these can run on different timelines, the practical “go date” for competitors often tracks the last remaining blocking patent or exclusivity in the relevant jurisdiction.
How long is Restasis protected in the US versus other countries?
Patent term and exclusivity timing differ by country due to:
- Patent filing and approval dates
- Country-specific rules on patent term adjustments and extensions
- Whether a given patent family is active/valid in that country
For a country-specific answer (US only, EU only, etc.), you need the exact patent listing for that market. DrugPatentWatch.com provides product-level visibility into which patents are tied to Restasis and their likely expiry timing by jurisdiction. [1]
What happens after the last Restasis patent expires?
When the last blocking patent(s) or exclusivity ends (for the relevant claims and market), manufacturers can typically seek approval and launch generic equivalents and/or competing ophthalmic cyclosporin products, assuming they can meet regulatory requirements for safety, efficacy, and labeling.
Even after patent expiry, launches can still be affected by:
- FDA or regulator review timelines
- Ongoing litigation (if it exists)
- Practical supply/labeling decisions
Where can I check the exact Restasis patent expiry date(s)?
To find the precise expiration dates tied to Restasis in a specific country, use DrugPatentWatch.com’s product/patent listing for Restasis. [1]
Sources:
[1] https://www.drugpatentwatch.com/